Scarica l'app Stockscreener
0.4654
2.51%
0.0114
Dopo l'orario di chiusura:
.46
-0.0054
-1.16%
Precedente Chiudi:
$0.454
Aprire:
$0.46
Volume 24 ore:
709.84K
Relative Volume:
0.50
Capitalizzazione di mercato:
$67.02M
Reddito:
-
Utile/perdita netta:
$-119.76M
Rapporto P/E:
-0.3447
EPS:
-1.35
Flusso di cassa netto:
$-55.17M
1 W Prestazione:
+13.15%
1M Prestazione:
-9.10%
6M Prestazione:
-16.85%
1 anno Prestazione:
-94.26%
Intervallo 1D:
$0.4574
$0.4799
Intervallo di 1 settimana:
$0.4129
$0.49
Portata 52W:
$0.295
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
Nome
Applied Therapeutics Inc
Settore
Industria
Telefono
212-220-9226
Indirizzo
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Confronta APLT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.4654 | 65.38M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-12-02 | Downgrade | UBS | Buy → Neutral |
| 2024-11-29 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-31 | Iniziato | William Blair | Outperform |
| 2024-03-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-02-22 | Iniziato | Leerink Partners | Outperform |
| 2022-01-04 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-08-27 | Downgrade | Goldman | Neutral → Sell |
| 2021-06-25 | Ripresa | Goldman | Neutral |
| 2020-10-08 | Iniziato | Truist | Buy |
| 2020-04-22 | Iniziato | Goldman | Buy |
| 2020-02-27 | Iniziato | Barclays | Overweight |
| 2019-06-10 | Iniziato | Citigroup | Buy |
| 2019-06-10 | Iniziato | Cowen | Outperform |
| 2019-06-10 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Applied Therapeutics Inc Borsa (APLT) Ultime notizie
Applied Therapeutics ($APLT) Is Paying a Settlement to Investors — Here’s How to Get Your Share - TradingView
Detecting price anomalies in Applied Therapeutics Inc. with AIMarket Growth Report & Breakout Confirmation Trade Signals - newser.com
When is the best time to exit Applied Therapeutics Inc.Market Risk Analysis & Weekly High Potential Alerts - newser.com
Is Applied Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Market Mood & Precise Buy Zone Tips - newser.com
Why Applied Therapeutics Inc. is moving today2025 EndofYear Setup & Community Consensus Stock Picks - newser.com
Will Applied Therapeutics Inc. continue its uptrendTrade Risk Summary & Reliable Entry Point Trade Alerts - newser.com
Applied Therapeutics Agrees to Pay Settlement to $APLT Investors — Here’s How to Get Your Share - TradingView
Automated trading signals detected on Applied Therapeutics Inc.July 2025 Pullbacks & Low Volatility Stock Suggestions - newser.com
Will Applied Therapeutics Inc. see short term momentumEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
2025-09-21 | Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation | NDAQ:APLT | Press Release - Stockhouse
Analysts Set Applied Therapeutics Inc. (NASDAQ:APLT) Target Price at $6.10 - MarketBeat
What MACD and RSI say about Applied Therapeutics Inc.Insider Selling & Stock Portfolio Risk Management - newser.com
Multi factor analysis applied to Applied Therapeutics Inc.July 2025 Breakouts & Long Hold Capital Preservation Plans - newser.com
Custom strategy builders for tracking Applied Therapeutics Inc.Risk Management & Stepwise Trade Signal Implementation - newser.com
What to expect from Applied Therapeutics Inc. in the next 30 daysJuly 2025 Setups & Risk Managed Investment Signals - newser.com
Predicting Applied Therapeutics Inc. trend using moving averages2025 Earnings Impact & Safe Capital Allocation Plans - newser.com
How to recover losses in Applied Therapeutics Inc. stockRate Hike & Low Drawdown Investment Strategies - newser.com
What moving averages say about Applied Therapeutics Inc.July 2025 PreEarnings & Community Shared Stock Ideas - newser.com
Signal strength of Applied Therapeutics Inc. stock in tech scannersMarket Activity Report & Technical Pattern Based Signals - newser.com
Evaluating Applied Therapeutics Inc. with trendline analysis2025 Bull vs Bear & Smart Money Movement Tracker - newser.com
Advanced analytics toolkit walkthrough for Applied Therapeutics Inc.2025 Market Sentiment & Reliable Price Action Trade Plans - newser.com
Is Applied Therapeutics Inc backed by strong institutional buyingWeekly Trade Report & Weekly Momentum Picks - khodrobank.com
Applied Therapeutics Inc. (NASDAQ:APLT) Receives $6.10 Average Target Price from Analysts - Defense World
Quarterly Recap: Can Applied Therapeutics Inc keep up with sector leadersPortfolio Performance Report & Daily Technical Stock Forecast Reports - خودرو بانک
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Elevance Health Inc. (NYSE: ELV); and V.F. Corp. (NYSE: VFC): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Applied Therapeutics Announces New Equity Offering Agreement - MSN
How moving averages guide Applied Therapeutics Inc. tradingMarket Sentiment Review & Safe Capital Preservation Plans - newser.com
Wall Street Recap: Can Applied Therapeutics Inc continue delivering strong returnsJuly 2025 Analyst Calls & Risk Controlled Swing Alerts - خودرو بانک
Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Stockholders to Connect - ACCESS Newswire
Important Notice to Long-Term Shareholders of Applied - GlobeNewswire
Smart Money: Can Applied Therapeutics Inc continue delivering strong returnsWall Street Watch & Pattern Based Trade Signal System - خودرو بانک
Can Applied Therapeutics Inc maintain sales growthMarket Growth Summary & Daily Stock Trend Reports - خودرو بانک
Market Trends: Can Applied Therapeutics Inc continue delivering strong returns2025 Growth vs Value & Daily Market Momentum Tracking - خودرو بانک
Quarterly Risk: What is Applied Therapeutics Incs valuation compared to sectorQuarterly Performance Summary & Real-Time Chart Pattern Alerts - خودرو بانک
Trading Recap: Is Applied Therapeutics Inc. in a bullish channelTrade Entry Summary & Fast Momentum Entry Tips - خودرو بانک
Portfolio Shifts: Is RNGR stock technically oversoldJuly 2025 Market Mood & Daily Entry Point Alerts - khodrobank.com
Update Report: Does Applied Therapeutics Inc. have strong fundamentals2025 Market Overview & AI Driven Price Predictions - خودرو بانک
Fed Watch: Will Applied Therapeutics Inc. benefit from sector rotationDay Trade & Safe Capital Growth Plans - خودرو بانک
Applied Therapeutics, Inc. (APLT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Applied Therapeutics Inc. stock trend forecast2025 Volatility Report & Weekly Consistent Profit Watchlists - newser.com
Applied Therapeutics Inc Azioni (APLT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.30%
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):